Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masaya Kobayashi, Mi-Na Kweon, Hirotaka Kuwata, Robert D. Schreiber, Hiroshi Kiyono, Kiyoshi Takeda, Shizuo Akira
Published in Volume 111, Issue 9
J Clin Invest. 2003; 111(9):1297–1308 doi:10.1172/JCI17085
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

IL-12/Stat3 double-mutant mice showed no inflammatory change in the colon. (a) Peritoneal macrophages were stimulated with 10 ng/ml LPS for 24 h. Concentrations of TNF-α, IL-6, and IL-12p40 in the culture supernatants were measured. *Not detected. (bd) Histopathology of the colons of (b) control, (c) IL-12–deficient, and (d) IL-12/Stat3 double-mutant mice at 16 weeks. H&E staining is shown. ×20. (e) The colitis score of IL-12/Stat3 double-mutant mice at 16 weeks of age. None of the IL-12/Stat3 double-mutant mice showed any inflammatory change in the colon. *P < 0.001 between Stat3 mutant mice and control or IL-12/Stat3 double-mutant mice.